Aldeyra Therapeutics is a biotechnology company engaged in developing and commercializing medicines for patients with immune-mediated diseases. The company's primary product candidate, reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. The company has additional product candidates in development for proliferative vitreoretinopathy and other retinal diseases, autoimmune disease, and cancer. The company has discovered and are developing two additional reactive aldehyde species inhibitors, ADX-103 and ADX-629, for the treatment of retinal disease and autoimmune disease, respectively.

At Home Group is a holding company. Through its subsidiaries, the company is a home decor superstore. The company's product mix includes home furnishings, which consists of accent furniture, furniture, mirrors, patio cushions, rugs and wall art. Accent decor consists of artificial flowers and trees, bath, bedding, candles, garden and outdoor decor, holiday accessories, home organization, pillows, pottery, vases and window treatments. The company operates its stores primarily in the South Central, Southeastern, Mid-Atlantic and Midwestern regions of the U.S. In addition, the company operates a distribution center and warehouse premises in Texas, which services its stores, and a second distribution center in Pennsylvania.

Cognizant Technology Solutions is a services company, transforming customers' business, operating and technology models for the digital era. The company's services include digital services and solutions, consulting, application development, systems integration, application testing, application maintenance, infrastructure services and business process services. Additionally, the company develops, licenses, implements and supports proprietary and third-party software products and platforms. The company has organized its services and solutions into four practice areas: Digital Business, Digital Operations, Digital Systems and Technology and Consulting.

CommScope Holding is a provider of infrastructure solutions for communication networks. The company's solutions and services for wired and wireless networks enable high-bandwidth data, video and voice applications. The company's operating segments are: CommScope Connectivity Solutions (CCS) and CommScope Mobility Solutions (CMS). The CCS segment is engaged in providing fiber optic and copper connectivity solutions for use in data centers and business enterprise, telecommunications, cable television and residential broadband networks. The CMS segment is engaged in providing infrastructure for wireless networks.

Domo provides a platform that digitally connects people, data and systems in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company's platform provides access to data through a set of connection options, including connectors. The company's data warehouse, Adrenaline, stores data from across the business. Fusion is the company's data transformation engine that sorts customer data. The company's Explorer analytics suite allows users to analyze, display, share and interact with data through visualizations. With the Domo Appstore, APIs and developer tool kits, the company enables an ecosystem of partners to build applications on the platform.

Nicholas Financial is a holding company. Through its subsidiary, Nicholas Financial, Inc., the company is engaged primarily in acquiring and servicing automobile finance installment contracts (Contracts) for purchases of used and new automobiles and light trucks. In addition, the company also originates direct consumer loans (Direct Loans) and sells consumer-finance related products. For Automobile Finance Business - Contracts, the company is engaged in the business of providing financing programs, on behalf of purchasers of used cars and light trucks. For Contract Procurement, the Contracts purchased by the company is for used vehicles. For Direct Loans, the loans originated directly between the company and the consumer.

Organogenesis Holdings is a regenerative medicine company focused on the development, manufacture and commercialization of solutions. The company's Advanced Wound Care products include Apligraf for the treatment of VLUs and DFUs; Dermagraft for the treatment of DFUs; PuraPly Antimicrobial (PuraPly AM) to address biofilm across various wound types; and Affinity and NuShield to address various wound sizes and types. The company's Surgical and Sports Medicine products include ReNu for in-office joint and tendon applications; NuCel for bony fusion in the spine and extremities; NuShield and Affinity for surgical application in targeted soft tissue repairs; and PuraPly AM for surgical treatment of open wounds.

Prudential is a parent holding company. Co., together with its subsidiaries, is an international financial services group with its principal operations in Asia, the U.S. and the U.K. In Asia, Co. has operations in Hong Kong, Indonesia, Malaysia, Singapore and other markets. In the U.S., Co.'s principal subsidiary is Jackson National Life Insurance Company. In the U.K., Co. operates through its subsidiaries, primarily The Prudential Assurance Company Limited and M&G Investment Management Limited. Co. provides a range of retail financial products and services and asset management services throughout these territories.